The Entire Future of American Public Health Is at Risk
It may not even be the one-in-10,000 risk of irreversible paralysis known as subacute sclerosing panencephalitis, which is ...
Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers
Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...
Nature4d
Pfizer settles largest ever fraud suit for off-label promotion
“The only regulated proposition is how the information is disseminated by pharmaceutical representatives ... there was an off-label issue in the background of that case, “the charge was ...